[Summary] 致力于用重组蛋白放射性药物进行肿瘤诊疗的新药研发公司
苏州智核生物成立于2015年,是一家以“用具有创新性的核医学诊疗产品,给患者带来希望”为使命的核医药公司,致力于为全球患者提供创新性的放射性核素诊疗药物,产品覆盖甲状腺癌、肿瘤放射性核素诊断药物与治疗药物等领域。公司成立至今已获得4轮累计超过2亿元的风险投资。
智核生物创建了具有自主知识产权的基于单域抗体的放射性药物发现、研发、生产技术平台,并按照cGMP标准建设并启用了数千平的放射性药物GMP车间(乙级资质)。公司前瞻性地布局了10多个创新核素诊断和治疗产品管线。国内*款人促甲状腺激素(rhTSH,智舒嘉®)已获批上市,填补了中国大陆用药空白。多个创新的针对肿瘤的放射性显影药物已经逐步进入临床,全新靶点的放射性治疗性药物获得潜在分子,即将启动临床。
What does 苏州智核生物医药科技有限公司 require? Who is 智核生物 hiring? 智核生物 recruitment: 销售类占比最多占72.7%,其次是医疗卫生/美容保健类占22.7%. What education can get in at 智核生物? 大专占比最多占77.3%,其次是本科占18.2%. High education required at 智核生物? 硕士占4.5%. Work experience required at 智核生物? 1-3年占比最多占59.1%,其次是不限占40.9%. Where are the job locations at 智核生物? 苏州占比最多占27.3%,其次是上海占13.6%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows